RHD and neoplasm: The results showed that treatments with artesunate (i.p. once daily at 25, 50, 100, and 150 mg/kg body weight) for 32 days in a dose-dependent manner inhibited the tumor growth (volume) of Rh30 xenografts in mice, by 23.6, 50.8%, 70.7%, and 80.3%, respectively, compared to the vehicle treatment (Figure 9A; Supplementary Figure S4).